Search results
Found 12434 matches for
Using MRI scans to target biopsies is more effective at detecting prostate cancers that are likely to need treatment than standard ultrasound guided biopsies alone, according to research published on 7 August in JAMA Network Open. The research, led by the National Institute for Health Research (NIHR) and Universities of Bristol, Ottawa, Exeter and Oxford, combined the results from seven studies covering 2,582 patients.
Sarah Howles
DPhil, FRCS (Urol), MA (Cantab), PGCert Sarah Howles - Associate Professor of Urology and Wellcome Trust Clinical Career Development Fellow
Regent Lee
MBBS, MS(Vasc Surg), DPhil (Oxon), FRCS (Vasc Surg) Regent Lee - Professor of Interdisciplinary Innovations
Artjoms Portnojs
Artjoms Portnojs - Deputy Laboratory Manager (Islet Isolation Laboratory)
Ágata Carreira
PhD Ágata Carreira - Postdoctoral Researcher in RNA Translation and Anti-Cancer Immunity
Martin Gillies
MA, BM BCh, PhD, MRCS, AFHEA Martin Gillies - Senior Research Fellow and Lecturer
Richard Bryant
Richard Bryant - Associate Professor of Urology and Academic Director of NDS SITU
Paul Johnson
MA MD FRCS (Paed.Surg) FAAP Paul Johnson - Director of Oxford Islet Isolation and Islet Transplant Programmes and Professor of Paediatric Surgery
Keith Al-Hasani
BA (French) BSc (Hon) PhD Keith Al-Hasani - Senior Postdoctoral Scientist